Grant: Team Grant: Diabetes Mechanisms and Translational Solutions - LOI - General
McMaster University
$10,000.00
Discovery of novel targets and pathways for diabetes remission
FY 2020-21
Summary
Type 2 diabetes has been previously considered a chronic progressive disease; however, new evidence suggests that it can be reversed. Our project is focused on identifying novel protein targets for inducing diabetes remission and discovering their mechanisms of action.
We have established a unique biobank of blood samples collected in 5 clinical trials in which we induced diabetes remission in patients with type 2 diabetes by using a combination of medical and lifestyle approaches. We propose to use this biobank as the first step for identifying novel proteins that change in people who undergo remission. We will then evaluate how these proteins relate to the development of new diabetes in a large international observational study. After identifying the top protein candidates for inducing diabetes remission, we will elucidate their mechanisms of action in animal models of diabetes as well as computer simulation models of multiple systems of the human body.
This study provides a unique opportunity to identify novel proteins related to remission of type 2 diabetes and help identify new drug targets for preventing and reversing this disease.
Department
Program
Team Grant: Diabetes Mechanisms and Translational Solutions - LOI - General
Recipient
Location
Ontario, Canada
Recipient Type
Academia
Type
Grant
Source
CIHR Funding Decisions Database
As published
Id
446661
Name
Mcinnes Natalia
Region
Ontario
Country
Canada
Orgtype
Institution Paid; Research Institution
Instname2
Nutrition, Metabolism and Diabetes
Theme2
Clinical
Prcname2
Team Grant: Diabetes Mechanisms and Translational Solutions - LOI
Projecttitle
Discovery of novel targets and pathways for diabetes remission
Programtype2
Operating Grants
Orgnameinp2
McMaster University
Cihramount2
$10,000
Cihrequipment2
$0
Programname2
Team Grant: Diabetes Mechanisms and Translational Solutions - LOI - General
Keyworddelim
Remission; Type 2 Diabetes
Abstract
Type 2 diabetes has been previously considered a chronic progressive disease; however, new evidence suggests that it can be reversed. Our project is focused on identifying novel protein targets for inducing diabetes remission and discovering their mechanisms of action.
We have established a unique biobank of blood samples collected in 5 clinical trials in which we induced diabetes remission in patients with type 2 diabetes by using a combination of medical and lifestyle approaches. We propose to use this biobank as the first step for identifying novel proteins that change in people who undergo remission. We will then evaluate how these proteins relate to the development of new diabetes in a large international observational study. After identifying the top protein candidates for inducing diabetes remission, we will elucidate their mechanisms of action in animal models of diabetes as well as computer simulation models of multiple systems of the human body.
This study provides a unique opportunity to identify novel proteins related to remission of type 2 diabetes and help identify new drug targets for preventing and reversing this disease.
Competitiondate
202012
Approvedterm2
1 yr 0 mth
Pinamesdelim
Mcinnes, Natalia; Gerstein, Hertzel C; Pigeyre, Marie; Poitout, Vincent; Steinberg, Gregory R
Approvedterm
1 an 0 mois
Cihrcontribution2
~ $10,000~ $0~